Evidence map›Paper›PMID 31871547›Full record

ReviewOxidative medicine and cellular longevity2019

Medical Application of Hydrogen in Hematological Diseases.

Liren Qian, Zhengcheng Wu, Jian Cen, Sergiu Pasca, Ciprian Tomuleasa

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Controlled Release of Hydrogen-Carrying Perfluorocarbons for Ischemia Myocardium-TargetingAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  7. Hydrogen Protection Boosts the Bioactivity ofAntioxidants (Basel, Switzerland) · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Liren QianDepartment of Hematology, The Sixth Medical Center, Chinese PLA General Hospital, China.ORCID https://orcid.org/0000-0002-7750-9177
Zhengcheng WuDepartment of Medical Service, The Sixth Medical Center, Chinese PLA General Hospital, China.
Jian CenDepartment of Hematology, The Sixth Medical Center, Chinese PLA General Hospital, China.
Sergiu PascaDepartment of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.
Ciprian TomuleasaDepartment of Hematology, Ion Chiricuta Oncology Institute, Cluj-Napoca, Romania.ORCID https://orcid.org/0000-0001-5500-1519
Chinese PLA General Hospital · CNIuliu Hațieganu University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrogen gas has been reported to have medical efficacy since the 1880s. Still, medical researchers did not pay much attention to hydrogen gas until the 20th century. Recent research, both basic and clinical, has proven that hydrogen is an important physiological regulatory factor with antioxidative, anti-inflammatory, and antiapoptotic effects. In the past two decades, more than 1000 papers have been published on the topic, including organ ischemia-reperfusion injury, radiation injury, diabetes, atherosclerosis, hypertension, or cancer. We have previously hypothesized and proven the therapeutic effects of hydrogen gas in graft-versus-host disease following stem cell transplantation. In the current manuscript, we present the clinical advances of hydrogen gas in hematological disorders.

Indexed as

AnimalsAnti-Inflammatory AgentsAntioxidantsApoptosisDisease Models, AnimalHumansHydrogenOxidative StressReperfusion InjuryAnti-Inflammatory AgentsAntioxidantsHydrogen

Identifiers

PMID31871547
PMCPMC6906850
OpenAlexW2990312257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.